CPRX Logo

Catalyst Pharmaceuticals, Inc. (CPRX) 

NASDAQ$20.87
Market Cap
$2.53B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
534 of 925
Rank in Industry
309 of 528

CPRX Insider Trading Activity

CPRX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$36,521,68925100

Related Transactions

Daly Richard JPresident and CEO0$01$276,735$-276,735
Harper Mollydirector0$02$471,949$-471,949
Tierney David Sdirector0$02$693,455$-693,455
Del Carmen JeffreyChief Commercial Officer0$03$1.48M$-1.48M
Elsbernd BrianChief Compliance/Legal Officer0$03$2.14M$-2.14M
Miller SteveChief Op. & Scientific Officer0$02$4.15M$-4.15M
INGENITO GARYChief Med. & Reg. Officer0$06$9.07M$-9.07M
MCENANY PATRICK JChairman of Board of Directors0$06$18.23M$-18.23M

About Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular â€¦

Insider Activity of Catalyst Pharmaceuticals, Inc.

Over the last 12 months, insiders at Catalyst Pharmaceuticals, Inc. have bought $0 and sold $36.52M worth of Catalyst Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Catalyst Pharmaceuticals, Inc. have bought $130,960 and sold $17.44M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 30,000 shares for transaction amount of $89,100 was made by MCENANY PATRICK J (President and CEO) on 2020‑09‑30.

List of Insider Buy and Sell Transactions, Catalyst Pharmaceuticals, Inc.

2025-03-06SaleINGENITO GARYChief Med. & Reg. Officer
180,096
0.1485%
$21.67$3.9M-3.28%
2025-03-05SaleINGENITO GARYChief Med. & Reg. Officer
44,904
0.0371%
$22.09$991,929-3.74%
2025-03-03SaleElsbernd BrianChief Compliance/Legal Officer
62,975
0.053%
$22.98$1.45M-3.97%
2025-03-03SaleDel Carmen JeffreyChief Commercial Officer
30,423
0.0255%
$22.89$696,382-3.97%
2024-12-10SaleMiller SteveChief Op. & Scientific Officer
50,000
0.0417%
$21.93$1.1M-0.11%
2024-11-27SaleINGENITO GARYChief Med. & Reg. Officer
12,000
0.0102%
$22.72$272,654-1.32%
2024-11-27SaleHarper Mollydirector
17,500
0.0144%
$22.00$385,000-1.32%
2024-11-26SaleElsbernd BrianChief Compliance/Legal Officer
13,256
0.011%
$21.63$286,704+0.64%
2024-11-20SaleMCENANY PATRICK JChairman of Board of Directors
72,500
0.0612%
$21.29$1.54M+3.88%
2024-11-20SaleINGENITO GARYChief Med. & Reg. Officer
38,000
0.032%
$21.20$805,562+3.88%
2024-11-19SaleMCENANY PATRICK JChairman of Board of Directors
98,345
0.0823%
$21.19$2.08M+2.71%
2024-11-14SaleMCENANY PATRICK JChairman of Board of Directors
44,655
0.0376%
$21.75$971,336+1.24%
2024-11-13SaleMCENANY PATRICK JChairman of Board of Directors
92,500
0.0776%
$22.98$2.13M-3.68%
2024-11-12SaleMCENANY PATRICK JChairman of Board of Directors
262,000
0.221%
$23.26$6.09M-4.69%
2024-11-11SaleMCENANY PATRICK JChairman of Board of Directors
230,000
0.1936%
$23.55$5.42M-6.33%
2024-08-21SaleTierney David Sdirector
15,000
0.0124%
$20.10$301,455+4.93%
2024-08-20SaleMiller SteveChief Op. & Scientific Officer
150,000
0.1243%
$20.35$3.05M+3.79%
2024-08-09SaleINGENITO GARYChief Med. & Reg. Officer
100,000
0.0826%
$18.04$1.8M+16.13%
2024-08-09SaleDel Carmen JeffreyChief Commercial Officer
36,058
0.0304%
$18.42$664,310+16.13%
2024-06-07SaleDel Carmen JeffreyChief Commercial Officer
7,541
0.0066%
$16.07$121,184+33.61%
Total: 237
*Gray background shows transactions not older than one year

Insider Historical Profitability

42.07%
MCENANY PATRICK JChairman of Board of Directors
4478169
3.6873%
$93.46M3614+56.08%
Miller SteveChief Op. & Scientific Officer
686996
0.5657%
$14.34M39+36.11%
Tierney David Sdirector
348874
0.2873%
$7.28M37+8.21%
BIOMARIN PHARMACEUTICAL INC10 percent owner
6666667
5.4892%
$139.13M10+100%
HUCKEL HUBERT E MDdirector
1304134
1.0738%
$27.22M50
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$193,151,375
134
8.18%
$2.71B
Catalyst Pharmaceuticals, Inc.
(CPRX)
$11,588,217
69
42.07%
$2.53B
$1,376,668
53
18.46%
$2.27B
$140,165,669
33
85.24%
$3.19B
$1,275,975,557
32
19.44%
$2.8B

CPRX Institutional Investors: Active Positions

Increased Positions203+68.58%11M+11.91%
Decreased Positions126-42.57%9M-9.16%
New Positions61New3MNew
Sold Out Positions36Sold Out2MSold Out
Total Postitions373+26.01%98M+2.75%

CPRX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$444,641.0016.05%19.43M+407,638+2.14%2024-12-31
Vanguard Group Inc$192,988.006.97%8.43M+390,116+4.85%2024-12-31
State Street Corp$132,683.004.79%5.8M+111,230+1.96%2024-12-31
Deerfield Management Company, L.P. (Series C)$71,715.002.59%3.13M-3M-49.71%2024-12-31
Dimensional Fund Advisors Lp$68,968.002.49%3.01M-5,757-0.19%2024-12-31
Pacer Advisors, Inc.$67,652.002.44%2.96M+151,495+5.4%2024-12-31
Goldman Sachs Group Inc$64,146.002.32%2.8M+1M+90.35%2024-12-31
Renaissance Technologies Llc$61,943.002.24%2.71M+180,100+7.13%2024-12-31
Geode Capital Management, Llc$61,013.002.2%2.67M+1,048+0.04%2024-12-31
First Trust Advisors Lp$51,132.001.85%2.23M-195,139-8.03%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
1.78SellsBuysStrong BuyBuyHoldSellStrong SellCPRXHighAverageLowSeries 4